Although RNAi technology is emerging as a major drug discovery engine,intrinsic drawbacks of siRNA have impeded its progress in clinic.1 Nowadays multifarious gene vectors have been developed to ameliorate the "siRNA druggability" dilemma.2Major achievements were surprisingly obtained indeed,however,several vital aspects also remained confusing and blurry,especially its intracellular biological behaviors.